←  News

LONGECITY


The above is an ad! Advertisements help to support the work of this non-profit organisation. To go ad-free join as a Member.
»

Ginsenoside Rg1 supplementation clears sen...

Engadin's Photo Engadin 10 Nov 2019

.

 

 

 

Posted today by smithx here.

 

 

 

 

F U L L   T E X T   S O U R C E :    ScienceDirect

 

 

 

 

 

Abstract
 
Background
 
Ginsenoside Rg1 has been shown to clear senescence-associated beta-galactosidase (SA-β-gal) in cultured cells. It remains unknown whether Rg1 can influence SA-β-gal in exercising human skeletal muscle.
 
 
Methods
 
To examine SA-β-gal change, 12 young men (age 21 ± 0.2 years) were enrolled in a randomized double-blind placebo controlled crossover study, under two occasions: placebo (PLA) and Rg1 (5 mg) supplementations 1 h prior to a high-intensity cycling (70% VO2max). Muscle samples were collected by multiple biopsies before and after cycling exercise (0 h and 3 h). To avoid potential effect of muscle biopsy on performance assessment, cycling time to exhaustion test (80% VO2max) was conducted on another 12 participants (age 23 ± 0.5 years) with the same experimental design.
 
 
Results
 
No changes of SA-β-gal were observed after cycling in the PLA trial. On the contrary, nine of the 12 participants showed complete elimination of SA-β-gal in exercised muscle after cycling in the Rg1 trial (p < 0.05). Increases in apoptotic DNA fragmentation (PLA: +87% vs. Rg1: +133%, p < 0.05) and CD68+ (PLA: +78% vs. Rg1: +121%, p = 0.17) occurred immediately after cycling in both trials. During the 3-h recovery, reverses in apoptotic nuclei content (PLA: +5% vs. Rg1: −32%, p < 0.01) and increases in inducible nitrate oxide synthase and interleukin 6 mRNA levels of exercised muscle were observed only in the Rg1 trial (p < 0.01).
 
 
Conclusion
 
Rg1 supplementation effectively eliminates senescent cells in exercising human skeletal muscle and improves high-intensity endurance performance.
 
 
 
 
.../...
 
 
 
 
 
 
 
 
.
Quote

Andey's Photo Andey 10 Nov 2019

I struggle to understand what apoptotic DNA levels means here.

I expected that if  substantial amount (from 1.5>>0.5% of total?) of senescent muscle cells go through apoptosis? than it should result in a prolonged release of DNA, meanwhile it even decreased at 3h mark compared to controls. 1% of cells could mean 100 grams worth of cells for 10kg muscle volume.

Could it imply that those cells havent gone though apoptosis and only switched their phenotype (probably only temporarily)?

Quote
Click HERE to rent this BIOSCIENCE adspot to support LongeCity (this will replace the google ad above).